Skip to content

AREX Capital Management, LP: XRAY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of AREX Capital Management, LP on XRAY, newest first. How the timeline and the estimate are built.

AREX Capital Management, LP held 0 XRAY shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -160,000 shares

    13F-HR 0000919574-26-001237 filed by AREX Capital Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 160,000 shares
    Change vs previous 13F +47,500 shares

    4.68% of the 13F portfolio, value $2,030,400.

    13F-HR 0000919574-25-006886 filed by AREX Capital Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 112,500 shares
    Change vs previous 13F +5,000 shares

    3.48% of the 13F portfolio, value $1,786,500.

    13F-HR 0000919574-25-004657 filed by AREX Capital Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 107,500 shares
    Change vs previous 13F +17,500 shares

    3.26% of the 13F portfolio, value $1,606,050.

    13F-HR 0000919574-25-003057 filed by AREX Capital Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 90,000 shares
    Change vs previous 13F not available

    2.43% of the 13F portfolio, value $1,708,200.

    13F-HR 0000919574-25-001162 filed by AREX Capital Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).